Aster DM Healthcare shareholding pattern

ASTERDM

666.95

17.10 (-2.50%)
Last updated on 13 Mar, 2026 | 15:45 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aster DM Healthcare Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2021-22
  • 2020-21
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

41.88%

Mutual Fund

22.24%

Insurance

0.19%

Foreign Institutional Investors

22.62%

Domestic Institutional Investors

0.48%

Retail

12.59%

Others

0%

Total Promoters
MAR '24
41.88%
JUN '24
41.88%
SEP '24
41.88%
DEC '24
41.88%

Summary

For Year 2025-26, Aster DM Healthcare reports the following shareholding: Total Promoters at 40.39%, Mutual Fund at 24.6%, Insurance at 1.05%, Foreign Institutional Investors at 18.46%, Domestic Institutional Investors at 0.47%, and Retail at 15.02%. This breakdown provides a quick snapshot of ownership distribution for Aster DM Healthcare in 2025-26.

Aster DM Healthcare FAQs

As of 03-2026, the promoter shareholding in Aster DM Healthcare stands at 40.39% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Aster DM Healthcare is 18.46% and 0.47% respectively.

The retail shareholding of the Aster DM Healthcare is 15.02%.

Changes in shareholding patterns of Aster DM Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Aster DM Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost